GERN250117C1000
- 1.90
- 0.000.00%
Geron Newsroom
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Barclays Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $9
Geron (GERN) Receives a Buy From Barclays
Strong Growth and Strategic Financial Management Bolster Buy Rating for Geron's Promising Rytelo Drug
Stifel Maintains Geron(GERN.US) With Buy Rating
Geron's Promising Market Growth: Strong Sales Performance and Optimistic Financial Guidance
Geron Updates on Q4 Revenue From U.S. Sales of RYTELO
Geron Analyst Ratings
Needham Maintains Geron(GERN.US) With Buy Rating, Raises Target Price to $7
Express News | Geron Corp : Needham Raises Target Price to $7 From $6
Geron to Showcase RYTELO Success at Healthcare Conference
Jingjin Electric (688280.SH): Shareholder Defeng Geron and its concerted parties have completed a Shareholding reduction of 0.52% of the company's shares.
Gelonghui reported on January 10 that Jingjin Electric (688280.SH) announced that the company recently received a notification letter regarding the shareholding reduction progress from Shareholder Defeng Geron and its concerted party Longhao Investment. As of January 10, 2025, Shareholder Defeng Geron and its concerted party Longhao Investment have reduced their shares of the company by 3,046,781 shares through centralized bidding, accounting for 0.52% of the company's total shares, and this shareholding reduction plan has been completed.
Geron Stock Rallies More Than 60% in a Year: Here's Why
Geron (NASDAQ:GERN) Shareholders Are Still up 181% Over 3 Years Despite Pulling Back 4.0% in the Past Week
Leerink Partners Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $7
Geron Inc.: Strategic Updates and Revised Launch Estimates Reinforce Buy Rating
Here's Why Geron Corp. (NASDAQ:GERN) Crashed Today
Why GERN Stock (GERN) Is Skyrocketing
Why Is Geron Corporation (GERN) Among the Best Biotech Penny Stocks to Invest in Now?